24 hour shipping | Hotel Delivery*
Call us today at 1-888-498-8040
Email Us at info@hghmx.com
Fast & Secure Payment Options:
Sogroya® is the first once-weekly growth hormone injection approved for both children and adults with growth hormone deficiency, offering an alternative to traditional daily injections. Sogroya contains somapacitan-beco, a long-acting human growth hormone analog, and is available in prefilled 5mg, 10mg, and 15mg pens. The ready-to-use pens require no mixing or separate cartridges and are administered just once per week. After first use, Sogroya can be stored refrigerated for up to 6 weeks and may be kept at room temperature (up to 25°C/77°F) for a total of up to 72 hours. Sogroya® is a registered trademark of Novo Nordisk Health Care AG.
Sogroya® is a long-acting growth hormone treatment that requires just one injection per week, rather than the daily injections traditionally associated with growth hormone therapy.
The Sogroya price can vary considerably depending on where you purchase your medication, the prescribed dosage, insurance coverage, and the amount of medication required. For families and adults facing high out-of-pocket costs in the United States, purchasing Sogroya in Mexico may provide a more affordable option.
At HGHmx, we help patients understand their medication requirements and the total cost before traveling, so you can compare your options and make an informed decision.
The cost of Sogroya in the United States can be significant, particularly for patients whose insurance does not cover growth hormone treatment or who have a high deductible or copay.
HGHmx provides access to authentic Sogroya in Mexico at significantly lower prices than many patients may encounter when paying out of pocket in the United States. The exact cost will depend on the Sogroya pen strength and quantity required by your prescription.
Contact our team for current Sogroya pricing and availability.
The biggest difference between Sogroya and traditional growth hormone treatments is its dosing schedule.
Sogroya contains somapacitan-beco, a long-acting growth hormone analog designed to be administered once weekly. By comparison, many established growth hormone medications require an injection every day.
This means a patient following a daily treatment could require approximately 365 injections per year, while a once-weekly Sogroya schedule requires approximately 52.
Sogroya was the first once-weekly growth hormone treatment approved in the United States for both children and adults with growth hormone deficiency, making it an important alternative for patients looking to reduce the frequency of injections.
Sogroya is approved for the treatment of pediatric patients aged 2.5 years and older who have growth failure due to inadequate secretion of endogenous growth hormone.
The once-weekly format may be particularly appealing to families looking for an alternative to administering growth hormone injections every day.
However, Sogroya is a prescription medication and the appropriate treatment, dosage and monitoring schedule must be determined by a qualified healthcare professional.
Sogroya is also approved for adults with growth hormone deficiency.
For eligible adults, the once-weekly injection provides an alternative to traditional daily growth hormone therapy. Your doctor will determine whether Sogroya is appropriate based on your diagnosis, medical history, laboratory results and other relevant factors.
If you are interested in purchasing Sogroya in Mexico, HGHmx can help coordinate the process.
Before purchasing Sogroya, you will need an appropriate medical evaluation and prescription. Our team can assist with coordinating the necessary consultation, bloodwork and medication so everything can be prepared around your trip to Mexico.
If you already have a diagnosis and prescription from your doctor in the United States, let our team know when you contact us so we can explain the options available to you.
Sogroya is a prescription growth hormone medication and should only be used under the supervision of a qualified healthcare professional.
Depending on your circumstances, the process may include reviewing your existing diagnosis and prescription, completing bloodwork, consulting with a doctor and determining the appropriate medication and dosage.
HGHmx can assist with coordinating these steps in Mexico and provide the medication and appropriate cold-storage supplies for your journey.
Sogroya is administered as a subcutaneous injection once per week using a prefilled injection pen.
Your prescribed dose should be determined by your healthcare professional. Injection sites should be rotated, and patients should receive appropriate instructions on how to prepare and use the pen before administering Sogroya themselves.
Always follow the instructions supplied with your medication and the directions provided by your prescribing healthcare professional. For complete preparation, injection and storage instructions, consult the official Sogroya prescribing information from Novo Nordisk.
There is no single Sogroya dosage that is appropriate for everyone.
Dosage differs between children and adults and may depend on factors including age, body weight, treatment history, response to therapy and individual medical circumstances.
Your prescribing doctor will determine your starting dose and may adjust it over time based on your response to treatment, IGF-1 levels and other clinical considerations.
Never change your Sogroya dosage without consulting your healthcare professional.
One of the most important differences between Sogroya and Norditropin is how frequently the medication is administered.
Norditropin contains somatropin and is generally administered daily, while Sogroya contains the long-acting growth hormone analog somapacitan-beco and is administered once weekly.
For some patients and families, reducing injections from seven times per week to once per week may make Sogroya an attractive option. However, the best growth hormone medication depends on the individual patient, diagnosis and prescribing doctor’s recommendation.
Sogroya contains somapacitan-beco, a long-acting human growth hormone analog. It is manufactured by Novo Nordisk, the pharmaceutical company that also manufactures Norditropin.
When purchasing growth hormone medication, authenticity and correct storage are extremely important. HGHmx supplies authentic medication sourced in Mexico and maintains appropriate handling and storage requirements.
Already using Sogroya? We would love to hear about your experience.
Sharing your experience may help other patients and families who are considering the transition from daily growth hormone injections to a once-weekly treatment understand what the experience is like.
Please leave an honest Sogroya review and tell us about your experience.
Sogroya represents a major change in growth hormone therapy by reducing the traditional daily injection schedule to just one injection per week.
As the first once-weekly growth hormone treatment approved for both children and adults with growth hormone deficiency, Sogroya may be an appealing option for eligible patients looking for a more convenient treatment schedule.
For patients and families struggling with the cost of growth hormone treatment in the United States, HGHmx can help you explore Sogroya pricing and availability in Mexico and coordinate the medical and prescription process required to obtain your medication safely.